GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Jointown Pharmaceutical Group Co Ltd (SHSE:600998) » Definitions » EPS (Basic)

Jointown Pharmaceutical Group Co (SHSE:600998) EPS (Basic) : ¥0.58 (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Jointown Pharmaceutical Group Co EPS (Basic)?

Jointown Pharmaceutical Group Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥0.19. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.58.

Jointown Pharmaceutical Group Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥0.19. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.58.

Jointown Pharmaceutical Group Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.26. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.73.

During the past 12 months, Jointown Pharmaceutical Group Co's average EPS without NRIGrowth Rate was 51.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 33.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Jointown Pharmaceutical Group Co's highest 3-Year average EPS without NRI Growth Rate was 33.30% per year. The lowest was -7.60% per year. And the median was 14.60% per year.


Jointown Pharmaceutical Group Co EPS (Basic) Historical Data

The historical data trend for Jointown Pharmaceutical Group Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jointown Pharmaceutical Group Co EPS (Basic) Chart

Jointown Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.47 0.40 0.43 0.50

Jointown Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.14 0.09 0.16 0.19

Jointown Pharmaceutical Group Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Jointown Pharmaceutical Group Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(2507.392-0)/5014.784
=0.50

Jointown Pharmaceutical Group Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(969.855-0)/5104.502
=0.19

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jointown Pharmaceutical Group Co  (SHSE:600998) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Jointown Pharmaceutical Group Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Jointown Pharmaceutical Group Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Jointown Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 5, Longxing West Street, Hanyang District, Hubei Province, Wuhan, CHN, 430051
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and primarily serves medical institutions, wholesale enterprises, and retail pharmacies.
Executives
Wang Qi Bing senior management
He Wei Directors, senior managers
Zhang Qing Song senior management
Yang Nie senior management
Liu Zhao Nian Director
Xu Ying Zheng Supervisors
Guo Lei senior management
Ai Hua Director
Gong Yi Hua Directors, senior managers
Lin Xin Yang Directors, senior managers
Yang Ju Mei senior management
Liu Yi Chang Director
Chen Qi Ming Directors, senior managers
Chen Li Supervisors
Liu Su Fang senior management

Jointown Pharmaceutical Group Co Headlines

No Headlines